CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 7 enrolled
Drug / intervention
Endoscopic Retrograde Cholangiopancreatography (ERCP)procedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01238341
NCT01238341N/ACompleted
CompareCT.gov

Prospective Evaluation of Clinical Utility of Endoscopic Retrograde Cholangiopancreatography (ERCP) With Overtube in Patients With Altered Gastric Anatomy

University of Florida·observational·Posted Nov 10, 2010·Updated Oct 23, 2015

In Brief

An observational study evaluating Endoscopic Retrograde Cholangiopancreatography (ERCP) for Pancreatobiliary Disease and Altered Gastric Anatomy. Completed, enrolled 7 participants across 1 site.

Detailed Summary

In patients, who have altered gastric anatomy and pancreatobiliary disease, the use of an endoscopic overtube to facilitate an Endoscopic Retrograde Cholangiopancreatography (ERCP).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatobiliary Disease, Altered Gastric Anatomy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 10, 2010
Enrollment StartJun 1, 2007
Primary CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 8.1 yearsPosted 15.6 years ago

Interventions

Endoscopic Retrograde Cholangiopancreatography (ERCP)procedure

An Endoscopic Retrograde Cholangiopancreatography (ERCP) performed with an overtube in the evaluation of pancreatobiliary disease in patients with altered gastric anatomy